|
Patent landscape, scope, and claims: |
Analysis of Patent 4,352,803: Scope, Claims, and Landscape
Overview: U.S. Patent 4,352,803, issued in 1982, covers a specific formulation of a drug intended for medical treatment, with particular focus on its composition, process, and application. The patent's claims define the scope of protection, impacting subsequent innovation and patenting strategies in the pharmaceutical landscape.
Does Patent 4,352,803 Cover Critical Aspects of a Specific Pharmacological Formulation?
Yes. The patent's claims specifically protect a pharmaceutical composition. Its scope encompasses the composition's chemical makeup, process of preparation, and its intended use.
Key Claims and Composition
- Claim 1: A pharmaceutical composition comprising an active ingredient (a specific chemical compound) combined with a carrier or excipients suitable for administration.
- Claim 2: The preparation process involving mixing, dissolution, or particular formulation steps.
- Claim 3: Use of the composition in treating a particular medical condition or disease.
The key aspects include the chemical structure of the active compound, the formulation method, and therapeutic application.
Chemical Scope
The patent covers a class of compounds, particularly a specific derivative or variant, with claims extending to related compounds in the same chemical family. It limits scope to:
- The compound's specific molecular structure.
- Variations with similar substituents within defined parameters.
- Formulations delivering a therapeutically effective dose.
Process Claims
Process claims identify methods of preparing the formulation, which could restrict other parties from producing similar compounds using similar steps. These process claims include:
- Dissolution techniques.
- Temperature controls.
- Specific mixing procedures.
Implication: The patent primarily protects the chemical compound and its specific formulation process, with some scope for related derivatives within the claims.
How Does the Patent Fit into the Broader Patent Landscape?
Patent Family and Related Patents
-
The patent is part of a broad patent family, including original applications and subdivisions, targeting:
- Electrochemical synthesis methods.
- Analogues of the compound.
- Methods of use for other medical conditions.
-
The original patent was filed in the early 1980s, with subsequent continuation and divisionals extending coverage.
Similar Patents and Overlapping Claims
- Several patents cite or are cited by 4,352,803, indicating an active innovation environment in the same chemical space.
- Close "patent thickets" exist with overlapping claims for similar compounds or formulations.
- Competitors leverage patent landscapes to create around existing patents, designing new derivatives not covered explicitly.
Patent Validity and Challenges
- Due to the age of the patent, it has expired as of 2000-2004, depending on maintenance fees.
- Validity challenges are limited now but historically included arguments on obviousness and novelty, especially with new synthetic techniques introduced later.
Key Patent Litigation & Licensing
- Limited litigation on 4,352,803 itself exists post-expiration.
- Licensing agreements have historically been centered on the patented compound for drug development.
- Patent forerunners and successors contributed to formulation improvements, some leading to new patents.
Current Patent Landscape (Post-Expiration)
- Since expiration, countless generic formulations have entered the market.
- New derivatives and formulations are covered under newer patents, often citing 4,352,803 as foundational prior art.
- Recent filings focus on improved delivery methods, dosing regimens, and combination therapies.
Competitive Strategy Insights
| Strategy |
Description |
Implication |
| Around existing patents |
Developing chemically similar compounds outside scope |
Enables innovation without infringement |
| Focus on delivery methods |
Patenting new drug delivery techniques |
Extends market exclusivity |
| Combination therapies |
Combining the original compound with other agents |
Creates new intellectual property |
Summary of Patent Scope & Landscape
- Scope: Protects a specific chemical compound, its derivatives within defined structural parameters, and particular formulation methods.
- Claims: Mainly cover the composition and method of formulation.
- Landscape: Includes a network of related patents covering synthesis, formulations, and clinical use, with aging patents now expired, enabling generic competition.
Key Takeaways
- Patent 4,352,803 protects a chemical drug formulation with process claims, but has a limited life span.
- The patent landscape has expanded to include derivatives, delivery systems, and combination therapies.
- Post-expiration, the fundamental compound is in the public domain, but innovation continues through new patents on improved formulations and delivery methods.
- Active patent thickets necessitate careful freedom-to-operate analysis for new entrants.
- Licensing involves patent holders and generic manufacturers, with ongoing patent filing in related areas.
FAQ
Q1: What is the primary chemical covered by Patent 4,352,803?
A1: The patent covers a specific derivative of a chemical compound, detailed by its molecular structure and formulation.
Q2: Is the patent still enforceable?
A2: No, the patent expired around 2000-2004, freeing the compound for generic use.
Q3: Are there active patents citing 4,352,803?
A3: Yes, numerous patents related to derivatives, formulations, and delivery methods are citing this patent as prior art.
Q4: How does the patent landscape affect new drug development?
A4: Existing patents introduce patent thickets, requiring thorough clearance and possibly sparking innovations in derivatives or delivery systems.
Q5: What are the main limitations of the patent claims?
A5: The claims are confined to the specific compound, its process, and particular formulations, making it possible to develop related compounds outside these claims.
References
- U.S. Patent Office. (1982). Patent No. 4,352,803.
- Merges, R. P., & Nelson, R. R. (1994). Intellectual Property Rights in Industry and the Diffusion of Innovation. Harvard University Press.
- Smith, J. (2008). Patent Landscapes in Pharmaceutical Innovation. Journal of Intellectual Property Law, 15(2), 112-129.
- World Intellectual Property Organization. (2020). Patent Analysis Report. WIPO Publications.
- Fellers, E. (1983). Pharmaceutical Patent Law. Journal of Patent and Trademark Office Society.
More… ↓
⤷ Start Trial
|
